Literature DB >> 24746305

Top dermatologic diagnoses by age.

Erin T Landis, Scott A Davis, Arash Taheri1, Steven R Feldman.   

Abstract

BACKGROUND: Although some skin conditions predominate in patients of certain ages, little data exists about the relative prevalence of dermatologic conditions by age.
OBJECTIVES: To determine the common skin conditions by age group in the United States, both in dermatologist samples and for all specialties.
METHODS: The National Ambulatory Medical Care Survey (NAMCS) was queried for top diagnoses at dermatologist and all skin disease visits from 1993-2010. ICD-9 coding was used for diagnoses.
RESULTS: There were 588 million estimated visits to dermatologists in the US from 1993-2010. Atopic dermatitis, acne, and actinic keratosis were the top diagnoses in all age groups. Common diagnoses in all groups included contact dermatitis and benign neoplasm. There were 740 million estimated skin disease visits to all physicians; more of these were acute or infectious. The percent of skin diseases seen by dermatologists gradually increased with age to a maximum of 55% in the 75-84 year age group.
CONCLUSION: Dermatologic conditions seen in different age groups and between dermatologists and non-dermatologists vary. With advancing age, Americans increasingly seek a dermatologist rather than a non-dermatologist physician for skin conditions.

Entities:  

Mesh:

Year:  2014        PMID: 24746305

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  16 in total

1.  Tolerability of Ingenol Mebutate Gel, 0.05%, for Treating Patients with Actinic Keratosis on the Scalp in a Community Dermatology Practice.

Authors:  Miriam S Bettencourt
Journal:  J Clin Aesthet Dermatol       Date:  2016-03-01

2.  [Dermatologic surgery on the scalp].

Authors:  W Koenen; C Kunte
Journal:  Hautarzt       Date:  2014-12       Impact factor: 0.751

3.  Efficacy and Tolerability of an Acne Treatment Regimen with Antiaging Benefits in Adult Women: A Pilot Study.

Authors:  Lily I Jiang; Peter D Hino; Lydia Parker; Thomas J Stephens; John Mccook; Vincent Gotz
Journal:  J Clin Aesthet Dermatol       Date:  2018-06-01

4.  Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials.

Authors:  Diane M Thiboutot; Leon Kircik; Amy McMichael; Fran E Cook-Bolden; Stephen K Tyring; David R Berk; Joan-En Chang-Lin; Vince Lin; Alexandre Kaoukhov
Journal:  J Clin Aesthet Dermatol       Date:  2016-10-01

5.  Use and Cost of Actinic Keratosis Destruction in the Medicare Part B Fee-for-Service Population, 2007 to 2015.

Authors:  Howa Yeung; Marissa L Baranowski; Robert A Swerlick; Suephy C Chen; Jennifer Hemingway; Danny R Hughes; Richard Duszak
Journal:  JAMA Dermatol       Date:  2018-11-01       Impact factor: 10.282

6.  Validation of International Classification of Disease Ninth Revision codes for atopic dermatitis.

Authors:  D Y Hsu; P Dalal; K A Sable; N Voruganti; B Nardone; D P West; J I Silverberg
Journal:  Allergy       Date:  2017-01-17       Impact factor: 13.146

7.  Community-Based Practice Variations in Topical Treatment of Actinic Keratoses.

Authors:  Molly Storer; Zheng Zhu; Monika Sokil; Margaret Ford; Romain Neugebauer; Maryam M Asgari
Journal:  JAMA Dermatol       Date:  2017-05-01       Impact factor: 10.282

Review 8.  Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update.

Authors:  Spencer M Vale; Dane Hill; Steven R Feldman
Journal:  Pharmacoeconomics       Date:  2017-02       Impact factor: 4.981

9.  The validity of diagnostic and treatment codes for actinic keratosis in electronic health records.

Authors:  O G Cohen; D J Margolis; M R Wehner
Journal:  Br J Dermatol       Date:  2020-01-14       Impact factor: 9.302

10.  Clinical Pharmacokinetics and Safety of a 10% Aminolevulinic Acid Hydrochloride Nanoemulsion Gel (BF-200 ALA) in Photodynamic Therapy of Patients Extensively Affected With Actinic Keratosis: Results of 2 Maximal Usage Pharmacokinetic Trials.

Authors:  Ben Novak; Janet DuBois; Osama Chahrour; Tamara Papusha; Stefan Hirt; Thomas Philippi; Corinna Zogel; Katharina Osenberg; Beate Schmitz; Hermann Lübbert
Journal:  Clin Pharmacol Drug Dev       Date:  2021-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.